Rigel reported a strong third quarter in 2024, with revenue of $55.3 million, significantly beating the consensus estimate of $38.3 million. This performance was largely driven by the impressive ...

On March 6, 2025, Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), a company specializing in pharmaceutical preparations with a market capitalization of $347 million and impressive revenue growth of 55% ...

Revenue: US$179.3m (up 55% from FY 2023). Net income: US$17.5m (up from US$25.1m loss in FY 2023). Profit margin: 9.8% (up from net loss in FY 2023). The move to profitability was driven by higher ...

These increases were partially offset by decreased research and development costs due to the timing of clinical trial activities related to R289, Rigel's dual IRAK 1/4 inhibitor program ...

Several research firms have recently issued reports on RIGL. B. Riley increased their price objective on shares of Rigel Pharmaceuticals from $17.00 to $27.00 and gave the stock a “neutral ...

The stuff of dreams for any archaeologist, Piers Litherland and his team, working on a British-Egyptian excavation, might have stumbled upon the second tomb of King Thutmose II in the Western ...

Jewelry was an important part of ancient Egyptian culture. Excavation at the Karnak temple found a 2,600-year-old pot filled with gold jewelry, beads, and statues. The statues of Egyptian gods ...

The tomb of Pharaoh Thutmose II is the first royal crypt discovered in recent years, and scientists have new powerful tools to analyze it. Egypt's Valley of the Kings is part of a massive ...

Meanwhile, foreign ministers from Muslim nations rejected calls by Mr Trump to remove the Palestinian population from Gaza, and instead backed the Egyptian plan. These ministers gathered in the ...

Speaking in Washington DC, Opposition Leader Yair Lapid presented on Tuesday a “day after” plan for Gaza, envisioning an extended Egyptian guardianship of the war-torn Strip. “Israel cannot ...